Kelly Steven 4

Accession 0001640334-24-000333

CIK 0001621221other

View on SEC.gov Company Profile

Filed

Feb 29, 7:00 PM ET

Accepted

Mar 1, 8:05 PM ET

Size

32.2 KB

Accession

0001640334-24-000333

Insider Transaction Report

Form 4

Period: 2024-02-28

ARTELO BIOSCIENCES, INC.ARTL

Kelly Steven

Director

Transactions

Disposition to Issuer
Stock Option (right to buy)
2024-02-28−1,484→ 0 total
Exercise: $29.85From: 2020-02-29Exp: 2029-08-29→ Common Stock (1,484 underlying)
Disposition to Issuer
Stock Option (right to buy)
2024-02-28−9,634→ 0 total
Exercise: $39.90From: 2023-02-12Exp: 2031-02-12→ Common Stock (9,634 underlying)
Disposition to Issuer
Stock Option (right to buy)
2024-02-28−667→ 0 total
Exercise: $15.00From: 2022-06-23Exp: 2031-07-16→ Common Stock (667 underlying)
Disposition to Issuer
Stock Option (right to buy)
2024-02-28−667→ 0 total
Exercise: $4.89From: 2023-06-24Exp: 2032-06-24→ Common Stock (667 underlying)
Disposition to Issuer
Stock Option (right to buy)
2024-02-28−667→ 0 total
Exercise: $1.99Exp: 2033-06-30→ Common Stock (667 underlying)
Disposition to Issuer
Stock Option (right to buy)
2024-02-28−1,083→ 0 total
Exercise: $2.01Exp: 2033-08-04→ Common Stock (1,083 underlying)
Award
Stock Option (right to buy)
2024-02-28+1,484→ 1,484 total
Exercise: $1.55Exp: 2029-08-29→ Common Stock (1,484 underlying)
Award
Stock Option (right to buy)
2024-02-28+9,634→ 9,634 total
Exercise: $1.55Exp: 2031-02-12→ Common Stock (9,634 underlying)
Award
Stock Option (right to buy)
2024-02-28+667→ 667 total
Exercise: $1.55Exp: 2031-07-16→ Common Stock (667 underlying)
Award
Stock Option (right to buy)
2024-02-28+667→ 667 total
Exercise: $1.55Exp: 2032-06-24→ Common Stock (667 underlying)
Award
Stock Option (right to buy)
2024-02-28+667→ 667 total
Exercise: $1.55Exp: 2033-06-30→ Common Stock (667 underlying)
Award
Stock Option (right to buy)
2024-02-28+1,083→ 1,083 total
Exercise: $1.55Exp: 2033-08-04→ Common Stock (1,083 underlying)

Footnotes (8)

[F1]This option was granted on August 29, 2019 and was previously reported as covering 22,250 shares at an exercise price of $1.99 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022.
[F2]The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the "Offer") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer).
[F3]This option was granted on February 12, 2021 and was previously reported as covering 144,500 shares at an exercise price of $2.66 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022.
[F4]This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022.
[F5]This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022.
[F6]Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan (the "Plan")) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean June 30, 2023.
[F7]Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean August 4, 2023.
[F8]Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month). "Amendment Date" shall mean February 28, 2024.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

ARTELO BIOSCIENCES, INC.

CIK 0001621221

→

Entity typeother

Related Parties

filerCIK 0001339478

Filing Metadata

Form type: 4
Filed: Feb 29, 7:00 PM ET
Accepted: Mar 1, 8:05 PM ET
Size: 32.2 KB

View on SEC.gov